Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

ale following approval. We have also designed the facility to be used as a contract manufacturing facility during those times (e.g., during certain times in the Phase III study) when we will not be producing Multikine. This lucrative business could quickly become a multi-million dollar revenue generator for CEL-SCI.

  • We presented very promising data on a new rheumatoid arthritis vaccine discovered by CEL-SCI scientists. The data presented was as good as that achieved with Enbrel, a leading treatment for rheumatoid arthritis.

  • We started planning and pricing our global clinical trial designed to lead to marketing approval for Multikine. The recent strength of the dollar will reduce our Phase III study costs by several million dollars.

While we are pleased by these accomplishments, we also recognize that there are major challenges due to the severe financial downturn. This downturn has affected all of us, but we have taken immediate action. We very quickly reduced our expenditures and expanded our discussions with various pharmaceutical companies for a world-wide Multikine partnership. Things are very difficult all around for most companies, but we are seeing new strength in the bigger biotechnology names. This will hopefully trickle down to the smaller ones like us as well. The huge buyouts in the industry, Pfizer buying Wyeth and Roche trying to buy Genentech, will add over $100 billion in liquidity to the industry, and that too should help us down the road.

Let me share with you how we at CEL-SCI are dealing with and planning for recovery from this financial downturn. In our opinion, during such a difficult time as this you cannot rely on one strategy alone. Therefore we are pursuing the following multi-pronged strategy. To
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... -- Decision Resources Group finds that the laparoscopic device market ... increase to a value of over $4.3 billion by ... the large direct energy device market. In particular, premium-priced ... to the advantages they offer and as new products ... Resources Group,s coverage of the U.S. laparoscopic device market: ...
(Date:12/19/2014)... Kan. , Dec. 18, 2014   ... ), a biopharmaceutical company focused on the licensing, ... animals, today announced positive results from its pivotal ... drug for treating pain in dogs with osteoarthritis. ... in pain assessment scores that were statistically significant ...
(Date:12/17/2014)... , December 17, 2014 Revenue and ... expenditure on research and development In the past ... revenue by two percent to EUR 4.287 billion (last year: ... by 14 percent to EUR 360 million. "Overall, 2013/14 was ... Michael Kaschke , President and CEO of Carl Zeiss ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS Asserts its Position in Difficult Environment 2
... with Leading Researchers having Clinical Experience with Antimicrobials ... April 22 NovaBay Pharmaceuticals, Inc. (NYSE Amex: ... developing first-in-class, potent, well-tolerated products to treat and ... chance of developing drug resistance, today announced an ...
... initiation of clinical studies; Data to be presented ... Drug discovery and development company Esperance Pharmaceuticals ... program that support the initiation of clinical ... from the Company,s Cationic Lytic Peptide (CLYP(TM)) platform ...
Cached Medicine Technology:NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds 2NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds 3NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds 4First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 2First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 3
(Date:12/21/2014)... Recently, BambooFlooringChina.com, a famous bamboo lumber ... flooring collection , and launched a bamboo flooring promotion ... valid until Jan. 30, 2015. , According to the ... hardest bamboo flooring available today; it has a highly ... teak hardwoods. Strand woven bamboo is made by a ...
(Date:12/21/2014)... 2014 When families in Coral Gables get ... call? The new answer is Lice Troopers . Located ... their newest treatment center will be the new go-to resource ... without the use of harmful chemicals or pesticides. ... 1, 2015. Like the company’s first clinic (located at 1005 ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Recently, one ... world, LunaDress Prom Shop has introduced its ... Christmas Sale, offering big discounts on all its prom ... off. , LunaDress insists on providing top quality dress ... and it is considered as one of the best ...
(Date:12/21/2014)... Parker & Sons, Inc. a market leader ... other similar home contractor services announces a record number ... expert contracting services. The company is considered by many ... Arizona for well over 40 years. Parker and Sons ... quality customer service to the residents and business owners ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 As ... alleging heart attacks, stroke and blood clots from using ... increase, a new study shows that the male hormone ... cancer. In a study published in the Proceedings of ... James Amos-Landgraf examined a group of male rats with ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4
... March 4 STAAR Surgical,Company (Nasdaq: STAA ... invasive ophthalmic products, congratulates Dr. Brian Boxer,Wachler on ... this morning,correcting NBCSports.com columnist Alan Abrahamson,s vision with ... the only foldable, minimally invasive lens approved,in the ...
... schools participate in 6th annual KID,HEALTHY--Steps to Healthy ... To combat the,rising trend of childhood obesity ... fifth grade students and parents from Los Angeles,Orange, ... schools and,after-school programs will participate in the KID ...
... acute kidney injury (AKI), an external device containing human ... significantly reduces the risk of death, according to a ... the American Society of Nephrology. , The experimental renal ... desperately ill patients with AKI. "Deployment of the ...
... Argosy Publishing, an award-winning interactive, visual content ... www.visiblebody.com ), the first free, Web-based 3-D interactive ... developed for educators, and health and medical professionals, ... that demonstrates how the human body works. It ...
... Spring Forward - it,s National Sleep Awareness Week, ... physician and,providers at Swedish Medical Center have transitioned ... Sleep Medicine Associates. The new medical group,founded by ... Swedish,Sleep Medicine Institute, will initially operate two centers ...
... the Wildlife Conservation Society, the BioDiversity Research Institute, ... environmental mercurymuch of which comes from human-generated emissionsis ... common loons in the Northeast. , The ... symbolic of northern lakes and wildernessappear in the ...
Cached Medicine News:Health News:STAAR Surgical's Visian ICL Procedure Performed Live on NBC's Today show 2Health News:STAAR Surgical's Visian ICL Procedure Performed Live on NBC's Today show 3Health News:Southern California Parents and Kids Take Healthy Steps in Tackling Childhood Obesity 2Health News:Southern California Parents and Kids Take Healthy Steps in Tackling Childhood Obesity 3Health News:'Renal Assist Device' reduces risk of death from acute kidney failure 2Health News:Argosy publishing launches The Visible Body 2Health News:Argosy publishing launches The Visible Body 3Health News:Sleep Medicine Associates Opens New Doors at Swedish - Cherry Hill Campus 2Health News:Scientists find mercury threatens next generation of loons 2
... Anchor is available in 3.5 mm, 5 mm ... minor diameter and a cancellous screw thread design ... laser mark on the distal part of the ... eyelets. When the anchor is inserted, the vertical ...
... - As easy to use as its ... demanding medical justification of therapeutic procedures. For ... tract symptoms (LUTS), that requires urodynamics. ... becoming routine in the office environment, with ...
... The FASTak II Suture Anchor is a ... that is inserted directly into bone without predrilling ... the Tear Drop Handle, Keyless Chuck or the ... and SLAP repairs as well as other small ...
... offer the best bioabsorbable solution for soft ... thread design and small core diameter provide ... braided suture loop is molded into the ... eyelet that virtually eliminates abrasion to attached ...
Medicine Products: